Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the ...

Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity ...

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Manufacturers to remove suicidal ideation warnings from Saxenda, Wegovy, and Zepbound labels following a large-scale FDA safety investigation.

Eli Lilly came to the 44 th annual JP Morgan Healthcare Conference bolstered by a strong year. 1 While the looming patent cliff still impacts that company’s upcoming strategy, Lilly found itself in a ...

Texas-founded partnership debuts a 12-week GLP-1 + food-as-medicine program built for sustainable metabolic health and employer-ready deploymentAUSTIN, ...

More than one-quarter of adults aged 25 to 64 years from 99 countries are eligible to receive a glucagon-like pepti ...

ATLANTA (AP) — Georgia’s governor said Wednesday that he wants to spend $1.8 billion to unclog one of traffic-choked ...